| scholarly article | Q13442814 |
| P2093 | author name string | A C Issekutz | |
| T B Issekutz | |||
| A Meager | |||
| I Otterness | |||
| P2860 | cites work | TNF alpha--a pivotal role in rheumatoid arthritis? | Q36092239 |
| Cytokines and endothelial cell biology | Q36565690 | ||
| Cytokines in autoimmune diseases | Q36756999 | ||
| Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice | Q37147228 | ||
| Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis | Q37253521 | ||
| Properties of the novel proinflammatory supergene "intercrine" cytokine family. | Q37357898 | ||
| The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome | Q37727453 | ||
| Endothelial cells and the pathogenesis of rheumatoid arthritis in humans and streptococcal cell wall arthritis in Lewis rats | Q37766092 | ||
| Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis | Q37908865 | ||
| Biochemical mechanisms of articular destruction | Q39687988 | ||
| Progress in the understanding of inducible models of chronic arthritis | Q39692113 | ||
| In vivo evidence that the rise in plasma IL 6 following injection of a fever-inducing dose of LPS is mediated by IL 1 beta | Q40762862 | ||
| TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy | Q40855796 | ||
| Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions | Q40859306 | ||
| Elevated levels of TNF in the joints of adjuvant arthritic rats | Q41545647 | ||
| Cytokine inter-relationships and their association with disease activity in arthritis | Q43530218 | ||
| Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis | Q44064388 | ||
| The beta form is the dominant interleukin 1 released by murine peritoneal macrophages | Q45262382 | ||
| Harvesting the noncirculating pool of polymorphonuclear leukocytes in rats by hetastarch exchange transfusion (HET): yield and functional assessment | Q46172411 | ||
| Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. | Q47589310 | ||
| Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo. | Q52074997 | ||
| Isolation and characterization of biologically active murine interleukin-1 alpha derived from expression of a synthetic gene in Escherichia coli. | Q54344684 | ||
| Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma. | Q54652889 | ||
| Control of vascular permeability by polymorphonuclear leukocytes in inflammation | Q59077548 | ||
| Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats | Q67545055 | ||
| Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor | Q67869949 | ||
| Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis | Q68028260 | ||
| Adjuvant arthritis | Q68032195 | ||
| T lymphocyte migration to arthritic joints and dermal inflammation in the rat: differing migration patterns and the involvement of VLA-4 | Q68033779 | ||
| Synergy between tumour necrosis factor alpha and interleukin-1 in the induction of polymorphonuclear leukocyte migration during inflammation | Q68092063 | ||
| Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis | Q68112952 | ||
| Reduction of biological activity of murine recombinant interleukin-1 beta by selective deamidation at asparagine-149 | Q68193901 | ||
| Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown | Q68888612 | ||
| Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells | Q69749410 | ||
| Quantitation and kinetics of polymorphonuclear leukocyte and lymphocyte accumulation in joints during adjuvant arthritis in the rat | Q70151438 | ||
| Vascular responses during acute neutrophilic inflammation. Their relationship to in vivo neutrophil emigration | Q70191158 | ||
| Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma | Q70385935 | ||
| Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies. Potential contribution from synovial fluid neutrophils | Q70750047 | ||
| Enhanced vascular permeability and haemorrhage-inducing activity of rabbit C5ades arg: probable role of polymorphonuclear leucocyte lysosomes | Q71395115 | ||
| Endotoxin activation of endothelium for polymorphonuclear leucocyte transendothelial migration and modulation by interferon-gamma | Q72234149 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 26-32 | |
| P577 | publication date | 1994-07-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis | |
| P478 | volume | 97 |
| Q51395500 | Amelioration of oxidative and inflammatory changes by Swertia chirayita leaves in experimental arthritis. |
| Q42045602 | Anti-inflammatory effects of systemic anti-tumour necrosis factor alpha treatment in human/murine SCID arthritis. |
| Q34071308 | Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha |
| Q28710288 | Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone |
| Q45258734 | Cytokine and nitric oxide production in the acute phase of bacterial cell wall-induced arthritis |
| Q74096072 | Cytokine mRNA in the joints and draining lymph nodes of rats with adjuvant arthritis and effects of cyclosporin A |
| Q78344990 | Effects of a PEGylated soluble TNF receptor type 1 (PEG sTNF-RI) on cytokine expression in adjuvant arthritis |
| Q36826576 | Female temperament, tumor development and life span: relation to glucocorticoid and tumor necrosis factor alpha levels in rats |
| Q79680822 | Gliadin peptides activate blood monocytes from patients with celiac disease |
| Q35547032 | Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34 |
| Q42276684 | Oxpentifylline inhibits tumor necrosis factor‐α mRNA transcription and protects against arthritis in mercuric chloride‐treated Brown Norway rats |
| Q45150273 | Potential role of heme oxygenase-1 in the progression of rat adjuvant arthritis |
| Q42943475 | Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation |
| Q72065803 | Role of cytokines in experimental arthritis |
| Q35797922 | Role of interleukin 1 in antigen-induced exacerbations of murine arthritis. |
| Q37229283 | Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis |
| Q73128904 | Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis |
| Q77982884 | The in vivo effects of tumour necrosis factor blockade on the early cell mediated immune events and syndrome expression in rat adjuvant arthritis |
| Q36224586 | The protein LJM 111 from Lutzomyia longipalpis salivary gland extract (SGE) accounts for the SGE-inhibitory effects upon inflammatory parameters in experimental arthritis model |
| Q71889641 | The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice |
| Q71707157 | Treatment of established adjuvant arthritis in rats with monoclonal antibody to CD18 and very late activation antigen-4 integrins suppresses neutrophil and T-lymphocyte migration to the joints and improves clinical disease |
| Q71612538 | Tumor necrosis factor priming of peripheral blood neutrophils from rheumatoid arthritis patients |
Search more.